Anna Mowry Biography and Net Worth

Anna is an experienced finance and business leader who joins Nautilus from Igneous where she served as VP of Finance and Operations with responsibility for finance, accounting, people, legal, and operations. Previously, Anna held a variety of roles at companies including Amazon Web Services and Isilon Systems, where she ultimately led the finance and sales operations organization. Anna has a BS in Biochemistry from Western Washington University and started her career at the Fred Hutchinson Cancer Research Institute. She earned her MBA from the University of Washington, leading her into a variety of finance and business roles of escalating responsibility.

What is Anna Mowry's net worth?: The estimated net worth of Anna Mowry is at least $244.85 thousand as of May 29th, 2025. Ms. Mowry owns 83,000 shares of Nautilus Biotechnology stock worth more than $244,850 as of April 11th. This net worth evaluation does not reflect any other investments that Ms. Mowry may own. Learn More about Anna Mowry's net worth.
How do I contact Anna Mowry?: The corporate mailing address for Ms. Mowry and other Nautilus Biotechnology executives is 51 ASTOR PLACE 10TH FLOOR, NEW YORK NY, 10003. Nautilus Biotechnology can also be reached via phone at 206-333-2001 and via email at [email protected]. Learn More on Anna Mowry's contact information.
Has Anna Mowry been buying or selling shares of Nautilus Biotechnology?: Anna Mowry has not been actively trading shares of Nautilus Biotechnology within the last three months. Most recently, on Thursday, May 29th, Anna Mowry bought 15,000 shares of Nautilus Biotechnology stock. The stock was acquired at an average cost of $0.77 per share, with a total value of $11,550.00. Following the completion of the transaction, the chief financial officer now directly owns 83,000 shares of the company's stock, valued at $63,910. Learn More on Anna Mowry's trading history.
Who are Nautilus Biotechnology's active insiders?: Nautilus Biotechnology's insider roster includes Mary Godwin (VP), Parag Mallick (Insider), Matthew Mcilwain (Director), Anna Mowry (CFO), Matthew Murphy (General Counsel), Sujal Patel (CEO), Matthew Posard (Director), and Kentaro Suzuki (CMO). Learn More on Nautilus Biotechnology's active insiders.
Are insiders buying or selling shares of Nautilus Biotechnology?: In the last year, Nautilus Biotechnology insiders bought shares 8 times. They purchased a total of 277,500 shares worth more than $240,250.00. The most recent insider tranaction occured on March, 4th when CEO Sujal M Patel bought 25,000 shares worth more than $65,250.00. Insiders at Nautilus Biotechnology own 41.1% of the company. Learn More about insider trades at Nautilus Biotechnology.
Information on this page was last updated on 3/4/2026.

Anna Mowry Insider Trading History at Nautilus Biotechnology

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/29/2025	Buy	15,000	$0.77	$11,550.00	83,000
8/19/2022	Buy	17,500	$2.30	$40,250.00	56,750
6/27/2022	Buy	5,500	$2.75	$15,125.00	39,250
8/12/2021	Buy	17,500	$7.71	$134,925.00

Anna Mowry Buying and Selling Activity at Nautilus Biotechnology

Nautilus Biotechnology Company Overview

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. It also offers proteome analysis system, a high-resolution optical imaging system for integrated fluidics and liquid handling sub-system. In addition, the company provides sample preparation, flow cells, multi-affinity probe reagents, and instrument buffers system to perform multi-cycle analysis runs. Nautilus Biotechnology, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.

Today's Range

Now: $2.95

$2.83

$3.18

50 Day Range

MA: $2.74

$2.01

$3.95

2 Week Range

Now: $2.95

$0.62

$4.31

Volume

392,953 shs

Average Volume

408,241 shs

Market Capitalization

$373.35 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.08